A clinical formulation indicated for Antiparasitics. This treatment supports the digestive system by limiting the ability of common intestinal parasites to absorb glucose and survive.
A broad-spectrum anthelmintic formulated to manage intestinal worm infestations and designed to alleviate symptoms by targeting parasitic growth and survival.
Mechanism of Action
It inhibits the formation of the worm's microtubules and selectively blocks glucose uptake. This depletes the energy of the parasite, leading to its death.
Route of Administration
Oral
Onset Time
1–3 days (for clearance)
Duration
Requires repeat dose in 2 weeks for pinworms
Contraindications
Pregnancy, Infants under 1 year, Allergy to mebendazole
Severe Adverse Events
Severe skin reactions (SJS), Liver function abnormalities, Convulsions, Severe allergic reaction
Information for Mebendazole is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.